These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5105870)

  • 1. The influence of prolonged amphetamine treatment and amphetamine withdrawal on brain biogenic amine content and behaviour in the rat.
    Herman ZS; Trzeciak H; Chruściel TL; Kmieciak-Kolada K; Drybański A; Sokola A
    Psychopharmacologia; 1971; 21(1):74-81. PubMed ID: 5105870
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of 1-(o-allylphenoxy)-3-isopropylamino-2-propanol hydrochloride (alprenolol) on the central nervous system of the rat.
    Herman ZS; Kmieciak-Kolada K; Drybański A; Sokola A; Trzeciak H; Chruściel TL
    Psychopharmacologia; 1971; 21(1):66-73. PubMed ID: 4398073
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigations into the mechanism of the influence of kinins on the action of amphetamine.
    Moniuszko-Jakoniuk J; Kościelak M; Wiśniewski K
    Pharmacology; 1978; 16(2):89-97. PubMed ID: 619367
    [No Abstract]   [Full Text] [Related]  

  • 4. Levels and distribution of central nervous system amines in normal and morphine-dependent monkeys.
    Segal M; Deneau GA; Seevers MH
    Neuropharmacology; 1972 Mar; 11(2):211-22. PubMed ID: 4623661
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of 4-chlorophenoxyamphetamine (A-6587), d-amphetamine and 4-chloroamphetamine on brain biogenic amines and behavior in mice.
    Everett GM; Yellin TO
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):407-13. PubMed ID: 4400361
    [No Abstract]   [Full Text] [Related]  

  • 6. A mechanism for the development of tolerance to amphetamine in rats.
    Lewander T
    Psychopharmacologia; 1971; 21(1):17-31. PubMed ID: 5567289
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue distribution of dl-3H-amphetamine HC1 in tolerant and nontolerant cats.
    Siegel M; Ellison T; Silverman AG; Okun R
    Proc West Pharmacol Soc; 1968; 11():90-4. PubMed ID: 5734494
    [No Abstract]   [Full Text] [Related]  

  • 8. Biogenic amines in various brain regions of growing cats.
    Pscheidt GR; Himwich HE
    Brain Res; 1966; 1(4):363-8. PubMed ID: 5961912
    [No Abstract]   [Full Text] [Related]  

  • 9. Biogenic amines in discrete brain areas after treatment with monoamineoxidase inhibitors.
    Valzelli L; Garattini S
    J Neurochem; 1968 Mar; 15(3):259-61. PubMed ID: 5638622
    [No Abstract]   [Full Text] [Related]  

  • 10. Microdetermination of norepinephrine, 3,4-dihydroxyphenylethylamine, and 5-hydroxyyptamine from single extracts of specific rat brain areas.
    Kariya T; Aprison MH
    Anal Biochem; 1969 Oct; 31(1):102-13. PubMed ID: 5380690
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of chronic imipramine administration on rat brain levels of serotonin, 5-hydroxyindoleacetic acid, norepinephrine and dopamine.
    Alpers HS; Himwich HE
    J Pharmacol Exp Ther; 1972 Mar; 180(3):531-8. PubMed ID: 5012780
    [No Abstract]   [Full Text] [Related]  

  • 12. Narcotic withdrawal like mouse jumping produced by amphetamine and L-DOPA.
    Lal H; Colpaert FC; Laduron P
    Eur J Pharmacol; 1975 Jan; 30(1):113-6. PubMed ID: 1168136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug interactions with brain biogenic amines and the effects of amphetamine isomers on locomotor activity.
    Zabik JE; Levine RM; Maickel RP
    Pharmacol Biochem Behav; 1978 Apr; 8(4):429-35. PubMed ID: 149988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and pharmacological studies on amineptine (S 1694) and (+)-amphetamine in the rat.
    Samanin R; Jori A; Bernasconi S; Morpugo E; Garattini S
    J Pharm Pharmacol; 1977 Sep; 29(9):555-8. PubMed ID: 21261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
    Beuthin FC; Miya TS; Blake DE; Bousquet WF
    J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
    [No Abstract]   [Full Text] [Related]  

  • 16. Anorectic activity of some amphetamine-derivatives with low CNS stimulating potency.
    Gemignani A; Versace P; Cugurra F; Vaccari A
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):88-101. PubMed ID: 4643290
    [No Abstract]   [Full Text] [Related]  

  • 17. A sensitive, rapid and simple method for the stimultaneous spectrophotofluorometric determinations of norepinephrine, dopamine, 5-hydroxytryptamine and 5-hydroxy-indoleacetic acid in discrete areas of brain.
    Cox RH; Perhach JL
    J Neurochem; 1973 Jun; 20(6):1777-80. PubMed ID: 4719320
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence that in rats 1-benzyl- -methoxy-3-trifluoromethylphenethylamine (SK& F 1-39728) dissociates anorexia from central stimulation and actions on brain monoamine stores.
    Groppetti A; Misher A; Naimzada M; Revuelta A; Costa E
    J Pharmacol Exp Ther; 1972 Sep; 182(3):464-73. PubMed ID: 5055405
    [No Abstract]   [Full Text] [Related]  

  • 19. A rapid, simplified procedure for simultaneous assay of norepinephrine, dopamine, and 5-hydroxytryptamine from discrete brain areas.
    Shellenberger MK; Gordon JH
    Anal Biochem; 1971 Feb; 39(2):356-72. PubMed ID: 5555466
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
    Proctor CD; Kirby J; Wood MH; Wade LH; King PK
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.